Cargando…
Deficiency of the Cyclin-Dependent Kinase Inhibitor, CDKN1B, Results in Overgrowth and Neurodevelopmental Delay
Germline mutations in the cyclin-dependent kinase inhibitor, CDKN1B, have been described in patients with multiple endocrine neoplasia (MEN), a cancer predisposition syndrome with adult onset neoplasia and no additional phenotypes. Here, we describe the first human case of CDKN1B deficiency, which r...
Autores principales: | Grey, William, Izatt, Louise, Sahraoui, Wafa, Ng, Yiu-Ming, Ogilvie, Caroline, Hulse, Anthony, Tse, Eric, Holic, Roman, Yu, Veronica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708111/ https://www.ncbi.nlm.nih.gov/pubmed/23505216 http://dx.doi.org/10.1002/humu.22314 |
Ejemplares similares
-
The CDK Subunit CKS2 Counteracts CKS1 to Control Cyclin A/CDK2 Activity in Maintaining Replicative Fidelity and Neurodevelopment
por: Frontini, Mattia, et al.
Publicado: (2012) -
Dual Suppression of the Cyclin-Dependent Kinase Inhibitors CDKN2C and CDKN1A in Human Melanoma
por: Jalili, Ahmad, et al.
Publicado: (2012) -
Fetal overgrowth in the Cdkn1c mouse model of Beckwith-Wiedemann syndrome
por: Tunster, Simon J., et al.
Publicado: (2011) -
Mitotic p21(Cip1/CDKN1A) is regulated by cyclin-dependent kinase 1 phosphorylation
por: Kreis, Nina-Naomi, et al.
Publicado: (2016) -
Upregulation of cyclin-dependent kinase inhibitors CDKN1B and CDKN1C in hepatocellular carcinoma-derived cells via goniothalamin-mediated protein stabilization and epigenetic modifications
por: Peng, Yu-Ting, et al.
Publicado: (2015)